Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GATA1 | GDSC1000 | pan-cancer | AAC | 0.35 | 2e-23 |
mRNA | CISH | CCLE | pan-cancer | AAC | 0.5 | 4e-23 |
mRNA | GBGT1 | GDSC1000 | pan-cancer | AAC | 0.35 | 4e-22 |
mRNA | ANKRD55 | GDSC1000 | pan-cancer | AAC | 0.34 | 5e-22 |
mRNA | KEL | GDSC1000 | pan-cancer | AAC | 0.35 | 5e-22 |
mRNA | GAB2 | CTRPv2 | pan-cancer | AAC | 0.34 | 6e-22 |
mRNA | ALAS2 | GDSC1000 | pan-cancer | AAC | 0.33 | 1e-21 |
mRNA | SOCS2 | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-21 |
mRNA | GAB2 | GDSC1000 | pan-cancer | AAC | 0.36 | 3e-21 |
mRNA | HBE1 | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-21 |